Videum
 
 
Touch Medical Media
Touch Medical Media

Touch Medical Media

Leading the Debate on the Advances in Healthcare

0 Followers
Share
106

ASH 2016 Shaji Kumar Interview

Dr Shaji Kumar reviews the rationale for targeting the BCL-2 protein in multiple myeloma (MM) and the results of the recent phase I study of venetoclax. He also discusses selinexor combination therapy and the role of minimal residual diseas...

Duration: 03:41
Licence: CC - Attribution
Original Language: English
Published: 12/12/2016
Diseases and Conditions: Multiple Myeloma
Format: Conference / Interviews / KOL

Other videos in this channel

 

Related Videos

ASH 2016 Shaji Kumar Interview

Comments (0)

Login to add your comment
Be the first to comment!